|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:692011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang YZ, Zhang LH, Gao Y, Li CH, Jia SQ,
Liu N, Cheng F, Niu DY, Cho WC, Ji JF and Zeng CQ: Discovery and
validation of prognostic markers in gastric cancer by genome-wide
expression profiling. World J Gastroenterol. 17:1710–1717. 2010.
View Article : Google Scholar
|
|
3
|
Zhai H, Acharya S, Gravanis I, Mehmood S,
Seidman RJ, Shroyer KR, Hajjar KA and Tsirka SE: Annexin A2
promotes glioma cell invasion and tumor progression. J Neurosci.
31:14346–14360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng L, Foley K, Huang L, Leubner A, Mo
G, Olino K, Edil BH, Mizuma M, Sharma R, Le DT, et al: Tyrosine 23
phosphorylation-dependent cell-surface localization of annexin A2
is required for invasion and metastases of pancreatic cancer. PLoS
One. 6:e193902011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang X, Liu S, Guo C, Zong J and Sun MZ:
The association of annexin A2 and cancers. Clin Transl Oncol.
14:634–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jacomo RH, Santana-Lemos BA, Lima AS,
Assis PA, Lange AP, Figueiredo-Pontes LL, Oliveira LO, Bassi SC,
Benício MT, Baggio MS, et al: Methionine-induced
hyperhomocysteinemia reverts fibrinolytic pathway activation in a
murine model of acute promyelocytic leukemia. Blood. 120:207–213.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Leal MF, Calcagno DQ, Chung J, de Freitas
VM, Demachki S, Assumpção PP, Chammas R, Burbano RR and Smith MC:
Deregulated expression of annexin-A2 and galectin-3 is associated
with metastasis in gastric cancer patients. Clin Exp Med. Jul
18–2014.(Epub ahead of print). View Article : Google Scholar
|
|
8
|
Deng S, Wang J, Hou L, Hou L, Li J, Chen
G, Jing B, Zhang X and Yang Z: Annexin A1, A2, A4 and A5 play
important roles in breast cancer, pancreatic cancer and laryngeal
carcinoma, alone and/or synergistically. Oncol Lett.
5:1072013.PubMed/NCBI
|
|
9
|
Yang T, Peng H, Wang J, Yang J, Nice EC,
Xie K and Huang C: Prognostic and diagnostic significance of
annexin A2 in colorectal cancer. Colorectal Dis. 15:e373–e381.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rodrigo JP, Lequerica-Fernandez P, Rosado
P, Rosado P, Allonca E, García-Pedrero JM and de Vicente JC:
Clinical significance of annexin A2 downregulation in oral squamous
cell carcinoma. Head Neck. 33:1708–1714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rodrigo JP, Garcia-Pedrero JM, Llorente
JL, Fresno MF, Allonca E, Suarez C and Hermsen M: Down-regulation
of annexin A1 and A2 protein expression in intestinal-type
sinonasal adenocarcinomas. Hum Pathol. 42:88–94. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yee DS, Narula N, Ramzy I, Boker J,
Ahlering TE, Skarecky DW and Ornstein DK: Reduced annexin II
protein expression in high-grade prostatic intraepithelial
neoplasia and prostate cancer. Arch Pathol Lab Med. 131:902–908.
2007.PubMed/NCBI
|
|
13
|
Wu A, Jia Y, Dong B, Tang L, Liu Y, Du H,
Yuan P, Dong P and Ji J: Apoptosis and KI67 index correlate with
preoperative chemotherapy efficacy and better predict the survival
of gastric cancer patients with combined therapy. Cancer Chemother
Pharmacol. 73:885–893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ,
Du H, Zhang GG, Hu Y, Lu AP, Li JY, et al: Positive association of
up-regulated Cripto-1 and down-regulated E-cadherin with tumour
progression and poor prognosis in gastric cancer. Histopathology.
52:560–568. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahn HS, Kim SH, Kodera Y and Yang HK:
Gastric cancer staging with radiologic imaging modalities and UICC
staging system. Dig Surg. 30:142–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seidah NG, Poirier S, Denis M, et al:
Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced
LDL receptor degradation. PLoS One. 7:e418652012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu MZ, Li ZH, Zhou ZW, Parker R, Miao B,
Mapelli C, Prat A, Wassef H, Davignon J, Hajjar KA, et al:
Detection of carcinoembryonic antigen messenger RNA in blood using
quantitative real-time reverse transcriptase-polymerase chain
reaction to predict recurrence of gastric adenocarcinoma. J Transl
Med. 8:1072010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hoffmann AC, Goekkurt E, Danenberg PV,
Lehmann S, Ehninger G, Aust DE and Stoehlmacher-Williams J: EGFR,
FLT1 and heparanase as markers identifying patients at risk of
short survival in cholangiocarcinoma. PLoS One. 8:e641862013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Q, Ye Z, Yang Q, et al: Upregulated
expression of annexin II is a prognostic marker for patients with
gastric cancer. World J Surg Oncol. 10:1032012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu XW, Xu Q, Xu Y, He X, Wang H and Zhao
Z: Expression of the E-cadherin/beta-catenin/tcf-4 pathway in
gastric diseases with relation to Helicobacter pylori infection:
Clinical and pathological implications. Asian Pac J Cancer Prev.
15:215–220. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rescher U and Gerke V: Annexins - unique
membrane binding proteins with diverse functions. J Cell Sci.
117:2631–2639. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mai J, Waisman DM and Sloane BF: Cell
surface complex of cathepsin B/annexin II tetramer in malignant
progression. Biochim Biophys Acta. 1477:215–230. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sharma MC and Sharma M: The role of
annexin II in angiogenesis and tumor progression: A potential
therapeutic target. Curr Pharm Des. 13:3568–3575. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao M, Li W, Wang H and Wang G: The
distinct expression patterns of claudin-10, -14, -17 and E-cadherin
between adjacent non-neoplastic tissues and gastric cancer tissues.
Diagn Pathol. 8:2052013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luo CH, Liu QQ, Zhang PF, Li MY, Chen ZC
and Liu YF: Prognostic significance of annexin II expression in
non-small cell lung cancer. Clin Transl Oncol. 15:938–946. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng S, Jing B, Xing T, Hou L and Yang Z:
Overexpression of annexin A2 is associated with abnormal
ubiquitination in breast cancer. Genomics Proteomics
Bioinformatics. 10:153–157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duncan R, Carpenter B, Main LC, Telfer C
and Murray GI: Characterisation and protein expression profiling of
annexins in colorectal cancer. Br J Cancer. 98:4262008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Swisher JF, Khatri U and Feldman GM:
Annexin A2 is a soluble mediator of macrophage activation. J Leukoc
Biol. 82:1174–1184. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Madureira PA, O'Connell PA, Surette AP,
Miller VA and Waisman DM: The biochemistry and regulation of
S100A10: A multifunctional plasminogen receptor involved in
oncogenesis. J Biomed Biotechnol. 2012:3536872012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He KL, Sui G, Xiong H, Broekman MJ, Huang
B, Marcus AJ and Hajjar KA: Feedback regulation of endothelial cell
surface plasmin generation by PKC-dependent phosphorylation of
annexin A2. J Biol Chem. 286:15428–15439. 2011. View Article : Google Scholar : PubMed/NCBI
|
